Cencora (COR) Competitors

Cencora (NYSE:COR) and McKesson (NYSE:MCK) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk, community ranking and media sentiment.

Is COR or MCK a better dividend stock?

Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.9%. McKesson pays an annual dividend of $2.84 per share and has a dividend yield of 0.5%. Cencora pays out 29.3% of its earnings in the form of a dividend. McKesson pays out 14.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cencora has increased its dividend for 15 consecutive years and McKesson has increased its dividend for 17 consecutive years.

Which has more volatility & risk, COR or MCK?

Cencora has a beta of 0.49, indicating that its stock price is 51% less volatile than the S&P 500. Comparatively, McKesson has a beta of 0.52, indicating that its stock price is 48% less volatile than the S&P 500.

Which has stronger valuation and earnings, COR or MCK?

McKesson has higher revenue and earnings than Cencora. McKesson is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cencora	$293.96B	0.16	$1.51B	$7.51	32.24
McKesson	$308.95B	0.24	$3.00B	$19.31	30.69

Does the MarketBeat Community favor COR or MCK?

McKesson received 226 more outperform votes than Cencora when rated by MarketBeat users. Likewise, 74.27% of users gave McKesson an outperform vote while only 65.38% of users gave Cencora an outperform vote.

Company	Underperform	Outperform
Cencora	Outperform Votes 744 65.38%	Underperform Votes 394 34.62%
McKesson	Outperform Votes 970 74.27%	Underperform Votes 336 25.73%

Does the media favor COR or MCK?

In the previous week, McKesson had 10 more articles in the media than Cencora. MarketBeat recorded 33 mentions for McKesson and 23 mentions for Cencora. McKesson's average media sentiment score of 1.34 beat Cencora's score of 1.30 indicating that McKesson is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cencora	19 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
McKesson	26 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts recommend COR or MCK?

Cencora presently has a consensus target price of $275.60, indicating a potential upside of 13.83%. McKesson has a consensus target price of $646.14, indicating a potential upside of 9.02%. Given Cencora's higher probable upside, research analysts plainly believe Cencora is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cencora	0 Sell rating(s)	2 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.82
McKesson	0 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	1 Strong Buy rating(s)	2.94

Is COR or MCK more profitable?

McKesson has a net margin of 0.77% compared to Cencora's net margin of 0.51%. Cencora's return on equity of 266.62% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cencora	0.51%	266.62%	4.20%
McKesson	0.77%	-207.50%	5.45%

Do insiders & institutionals believe in COR or MCK?

97.5% of Cencora shares are held by institutional investors. Comparatively, 85.1% of McKesson shares are held by institutional investors. 15.8% of Cencora shares are held by company insiders. Comparatively, 0.1% of McKesson shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

McKesson beats Cencora on 16 of the 22 factors compared between the two stocks.